Search research articles
Contact Us
Filters
Showing results (41-50 of 131) with videos related to
Page
of 14
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2014
Revised McDonald criteria for multiple sclerosis diagnostics in central Russia: sensitivity and specificity
A N Belova, I V Shalenkov, D N Shakurova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 27, 2020
[The role of mitochondria in pathological mechanisms of innate immunity in multiple]
A N Boyko, M V Melnikov, M S Kozin, et al.
Molekuliarnaia Biologiia
|
August 10, 2019
[Genetic Markers for Personalized Therapy of Polygenic Diseases: Pharmacogenetics of Multiple Sclerosis]
E Yu Tsareva, O O Favorova, A N Boyko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 13, 2021
[Treatment of multiple sclerosis with glatiramer acetate: a new look]
A N Boyko, N F Smirnova, I A Shchukin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 1, 2022
[Expression analysis of miRNAs from the DLK1-DIO3 locus in CD4+ and CD14+ cells in patients with relapsing-remitting multiple sclerosis]
N M Baulina, A R Kabaeva, A N Boyko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 22, 2017
[A prospective, open, non-randomized study on the safety and efficacy of natalizumab (tisabri) in the Russian population of patients with relapsing-remitting multiple sclerosis]
A N Boyko, E P Evdoshenko, O V Vorob'eva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 13, 2021
[Ofatumumab - a new drug for the treatment of multiple sclerosis]
A N Boyko, N F Smirnova, I A Shchukin, et al.
Human Genetics
|
September 27, 2015
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches
V V Bashinskaya, O G Kulakova, A N Boyko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 15, 2020
[Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab]
O V Boyko, I I Choroshilova, S V Petrov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
November 19, 2025
[Comparison of methods for assessing the severity of multiple sclerosis based on a sample of patients from the Moscow region]
O G Kulakova, M S Kozin, I S Kiselev, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 131) with videos related to
Sort By:
Page
of 14
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
August 23, 2014
Revised McDonald criteria for multiple sclerosis diagnostics in central Russia: sensitivity and specificity
A N Belova, I V Shalenkov, D N Shakurova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 27, 2020
[The role of mitochondria in pathological mechanisms of innate immunity in multiple]
A N Boyko, M V Melnikov, M S Kozin, et al.
Molekuliarnaia Biologiia
|
August 10, 2019
[Genetic Markers for Personalized Therapy of Polygenic Diseases: Pharmacogenetics of Multiple Sclerosis]
E Yu Tsareva, O O Favorova, A N Boyko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 13, 2021
[Treatment of multiple sclerosis with glatiramer acetate: a new look]
A N Boyko, N F Smirnova, I A Shchukin, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 1, 2022
[Expression analysis of miRNAs from the DLK1-DIO3 locus in CD4+ and CD14+ cells in patients with relapsing-remitting multiple sclerosis]
N M Baulina, A R Kabaeva, A N Boyko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
June 22, 2017
[A prospective, open, non-randomized study on the safety and efficacy of natalizumab (tisabri) in the Russian population of patients with relapsing-remitting multiple sclerosis]
A N Boyko, E P Evdoshenko, O V Vorob'eva, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
August 13, 2021
[Ofatumumab - a new drug for the treatment of multiple sclerosis]
A N Boyko, N F Smirnova, I A Shchukin, et al.
Human Genetics
|
September 27, 2015
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches
V V Bashinskaya, O G Kulakova, A N Boyko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
January 15, 2020
[Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab]
O V Boyko, I I Choroshilova, S V Petrov, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|
November 19, 2025
[Comparison of methods for assessing the severity of multiple sclerosis based on a sample of patients from the Moscow region]
O G Kulakova, M S Kozin, I S Kiselev, et al.
Page
of 14